VIH : recherche actuelle
Libre accès

Abstrait

Research on an HIV vaccine: The Difficulties and the Possibilities

Govind Gunakamadeva

HIV infection, which was once terminally ill, is now a chronic disease with a longer lifespan thanks to ongoing diagnostic and treatment advancements. Initially, these advantages were only available to patients in Resource-Rich Countries (RRCs), there has been a global movement to give millions of HIV-infected people in Resource-Limited Countries (RLCs) access to antiretrovirals . Most committed individuals receiving the most recent Combination Antiretroviral Therapy (cART) achieve viral suppression. While assays that look for latent tissue reservoirs with integrated viral DNA have revealed new information about treatment objectives, the cause of viral rebound when treatment is administered, and continued low-level viremia in patients who appear to be "suppressed," viral load tests with greater sensitivity have improved our understanding of these two factors.